Latest Regulatory Compliance News

SIV Capital Limited reported a sharp increase in losses for the half-year ending December 2024 and remains suspended from ASX trading due to operational concerns. The company is exploring acquisitions to leverage substantial tax losses and restore market confidence.

Bryah Resources has successfully completed the first tranche of its capital raising, securing $370,542 to fund copper exploration and working capital. The company now looks ahead to shareholder approval for the next phase of its placement.

Elixir Energy Limited's shares have been suspended from trading pending a significant announcement about expanding its Taroom Trough position, signaling potential strategic growth in its energy assets.

Macquarie Group’s 3Q25 trading update reveals strong growth in its annuity-style businesses, while markets-facing segments face pressure from subdued commodity markets, resulting in a mixed financial performance for the year to date.

Macquarie Group's 3Q25 trading update reveals strong growth in annuity-style businesses offset by a significant decline in markets-facing segments due to subdued commodity markets. The group's capital position remains robust, comfortably exceeding regulatory requirements.

Gladiator Resources has acknowledged a breach of its Securities Trading Policy following an on-market trade during a Black-Out Period, prompting a review of its compliance framework. The company reassures investors that subsequent trades were compliant and that governance standards remain a priority.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.

VIP Gloves Limited has obtained a short-term interest-free loan of approximately AUD$1 million ahead of a planned share placement, as it faces potential delisting from the ASX pending a critical reinstatement decision.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

E79 Gold Mines responds to ASX inquiries about recent price and volume spikes, linking market activity to a neighbour's gold find near its Laverton South Project.

Cannindah Resources Limited has responded to an ASX price query, confirming no undisclosed information explains recent stock price movements and affirming compliance with continuous disclosure rules.